Cart
sales@molnova.com
4-(Imidazol-1-yl)phenol
CAS No. 10041-02-8
4-(Imidazol-1-yl)phenol( —— )
Catalog No. M32723 CAS No. 10041-02-8
4-(Imidazol-1-yl)phenol is a potent signal enhancer in horseradish peroxidase (HRP)–luminol chemiluminescence (CL) immunoassays .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-(Imidazol-1-yl)phenol
-
NoteResearch use only, not for human use.
-
Brief Description4-(Imidazol-1-yl)phenol is a potent signal enhancer in horseradish peroxidase (HRP)–luminol chemiluminescence (CL) immunoassays .
-
Description4-(Imidazol-1-yl)phenol is a highly potent signal enhancer in a horseradish peroxidase (HRP)-luminol chemiluminescence (CL) immunoassay.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10041-02-8
-
Formula Weight160.176
-
Molecular FormulaC9H8N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(cc1)-n1ccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yannis Dotsikas, et al.Employment of 4-(1-imidazolyl)phenol as a luminol signal enhancer in a competitive-type chemiluminescence immunoassay and its comparison with the conventional antigen–horseradish peroxidase conjugate-based assay. Analytica Chimica Acta. Volume 509, Issue 1, 29 April 2004, Pages 103-109.
molnova catalog
related products
-
Cuscutamine
Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation.
-
Desmethyl Levofloxac...
Desmethyl Levofloxacin is a metabolite of Levofloxacin. Levofloxacin, a synthetic fluoroquinolone, is an antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
-
BMS986260
BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM). BMS-986260?demonstrated functional activity in multiple TGFβ-dependent cellular assays, excellent kinome selectivity, favorable pharmacokinetic properties, and curative in vivo efficacy in combination with anti-PD-1 antibody in murine colorectal cancer (CRC) models.?
